Great Lakes Advisors LLC Purchases 74,016 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Great Lakes Advisors LLC increased its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 113.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 139,116 shares of the company's stock after acquiring an additional 74,016 shares during the period. Great Lakes Advisors LLC owned about 0.28% of Prestige Consumer Healthcare worth $10,864,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the company. HighTower Advisors LLC raised its holdings in Prestige Consumer Healthcare by 89.5% in the 4th quarter. HighTower Advisors LLC now owns 31,666 shares of the company's stock worth $2,473,000 after acquiring an additional 14,958 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Prestige Consumer Healthcare by 7.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,053 shares of the company's stock worth $863,000 after acquiring an additional 731 shares during the last quarter. Amundi raised its holdings in Prestige Consumer Healthcare by 187.4% in the 4th quarter. Amundi now owns 25,669 shares of the company's stock worth $1,909,000 after acquiring an additional 16,737 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in Prestige Consumer Healthcare by 5.9% in the 4th quarter. PNC Financial Services Group Inc. now owns 5,276 shares of the company's stock worth $412,000 after acquiring an additional 296 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Prestige Consumer Healthcare in the 4th quarter worth approximately $42,593,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on PBH shares. Sidoti lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price objective for the company. in a report on Monday, December 9th. Oppenheimer lifted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. StockNews.com downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Monday, March 10th. DA Davidson lifted their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Finally, Raymond James raised shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research report on Thursday, December 19th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and an average price target of $92.60.

Prestige Consumer Healthcare Stock Performance

Shares of PBH stock traded up $0.94 during mid-day trading on Friday, reaching $83.77. 258,095 shares of the company's stock traded hands, compared to its average volume of 333,965. Prestige Consumer Healthcare Inc. has a 12 month low of $62.35 and a 12 month high of $90.04. The firm has a 50 day moving average price of $81.47 and a two-hundred day moving average price of $78.27. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The firm has a market capitalization of $4.15 billion, a PE ratio of 19.62, a price-to-earnings-growth ratio of 2.69 and a beta of 0.46.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Insider Activity

In related news, SVP Mary Beth Fritz sold 1,678 shares of the company's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total value of $151,020.00. Following the completion of the transaction, the senior vice president now owns 17,157 shares of the company's stock, valued at approximately $1,544,130. This represents a 8.91 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.